SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report
Identifieur interne : 002F17 ( Istex/Corpus ); précédent : 002F16; suivant : 002F18SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report
Auteurs : Alastair Wilkins ; Jerry M. Brown ; Roger A. BarkerSource :
- Movement Disorders [ 0885-3185 ] ; 2004-05.
English descriptors
- KwdEn :
- Abnormal, Abnormal activity, Abnormal movements, Acta, Acta neuropathol, Allele, Anterocollis, Ataxia, Atrophy, Autosomal, Axial right, Basal, Basal ganglia, Biceps brachii, Bilateral, Bilateral stimulation, Bilaterally, Botox, Botulinum, Botulinum toxin, Botulinum toxin type, Bradykinesia, Case report, Caudate, Caudate nucleus, Cerebellar, Cerebellar ataxia, Cervical, Cervical dystonia, Chorea, Choreic movements, Choreiform, Choreiform movements, Clinical features, Clinical outcome, Cogwheel rigidity, Colli, Contralateral, Cyclohydrolase, Deep brain stimulation, Degenerative ataxias, Dentatorubral, Dentatorubral pallidoluysian atrophy, Disord, Disorder, Dopamine, Drpla, Dyskinesia, Dystonia, Dystonic, Dystonic posture, Extrapyramidal, Familial cases, Family history, Ganglion, Genet, Genetic studies, Globus, Globus pallidum, Globus pallidus, Globus pallidus internus, Hereditary, Imaging, Inclusion, Interscience, Intramuscular, Intranuclear, Intranuclear inclusions, Involuntary movements, Jerk, Lancet, Longus, Longus colli, Magnetic resonance imaging, Moderate improvement, Movement disorder society, Movement disorders, Mutant, Mutation, Myoclonus, Nding, Ndings, Neurol, Neurol neurosurg psychiatry, Neurological, Neurology, Neuron, Neuronal, Neuropathological, Neuropathological features, Neurosurg, Normal values, October, Online, Oromandibular dystonia, Pallidal, Pallidal stimulation, Pallidoluysian, Pallidum, Pallidus, Parkinsonism, Perfusion, Phenotype, Propriospinal, Propriospinal myoclonus, Puncture site, Putamen, Radcliffe oxford, Rectus, Rectus abdominis, Rectus femoris, Right longus colli muscle, Rinsho shinkeigaku, Sca1, Sca2, Sca2 allele, Senile chorea, Several years, Severe anterocollis, Side effects, Single photon emission tomography, Spasmodic torticollis, Spet, Spinal, Spinocerebellar, Spinocerebellar ataxia, Spinocerebellar ataxia type, Sporadic case, Sporadic cases, Sternocleidomastoid, Sternocleidomastoid muscle, Sternocleidomastoid muscles, Sternocleidomastoideus, Stimulation, Stimulator, Subthalamic, Subthalamic nucleus, Symptom, Tardive, Tardive dyskinesia, Thalamic, Thalamic stimulation, Thalamus, Tohoku university school, Tomography, Torticollis, Toxin, Tremor, Trinucleotide, Trinucleotide expansion, Unilateral stimulation, Ventralis oralis, Video, Video segment, Videotape, Wiley interscience.
- Teeft :
- Abnormal, Abnormal activity, Abnormal movements, Acta, Acta neuropathol, Allele, Anterocollis, Ataxia, Atrophy, Autosomal, Axial right, Basal, Basal ganglia, Biceps brachii, Bilateral, Bilateral stimulation, Bilaterally, Botox, Botulinum, Botulinum toxin, Botulinum toxin type, Bradykinesia, Case report, Caudate, Caudate nucleus, Cerebellar, Cerebellar ataxia, Cervical, Cervical dystonia, Chorea, Choreic movements, Choreiform, Choreiform movements, Clinical features, Clinical outcome, Cogwheel rigidity, Colli, Contralateral, Cyclohydrolase, Deep brain stimulation, Degenerative ataxias, Dentatorubral, Dentatorubral pallidoluysian atrophy, Disord, Disorder, Dopamine, Drpla, Dyskinesia, Dystonia, Dystonic, Dystonic posture, Extrapyramidal, Familial cases, Family history, Ganglion, Genet, Genetic studies, Globus, Globus pallidum, Globus pallidus, Globus pallidus internus, Hereditary, Imaging, Inclusion, Interscience, Intramuscular, Intranuclear, Intranuclear inclusions, Involuntary movements, Jerk, Lancet, Longus, Longus colli, Magnetic resonance imaging, Moderate improvement, Movement disorder society, Movement disorders, Mutant, Mutation, Myoclonus, Nding, Ndings, Neurol, Neurol neurosurg psychiatry, Neurological, Neurology, Neuron, Neuronal, Neuropathological, Neuropathological features, Neurosurg, Normal values, October, Online, Oromandibular dystonia, Pallidal, Pallidal stimulation, Pallidoluysian, Pallidum, Pallidus, Parkinsonism, Perfusion, Phenotype, Propriospinal, Propriospinal myoclonus, Puncture site, Putamen, Radcliffe oxford, Rectus, Rectus abdominis, Rectus femoris, Right longus colli muscle, Rinsho shinkeigaku, Sca1, Sca2, Sca2 allele, Senile chorea, Several years, Severe anterocollis, Side effects, Single photon emission tomography, Spasmodic torticollis, Spet, Spinal, Spinocerebellar, Spinocerebellar ataxia, Spinocerebellar ataxia type, Sporadic case, Sporadic cases, Sternocleidomastoid, Sternocleidomastoid muscle, Sternocleidomastoid muscles, Sternocleidomastoideus, Stimulation, Stimulator, Subthalamic, Subthalamic nucleus, Symptom, Tardive, Tardive dyskinesia, Thalamic, Thalamic stimulation, Thalamus, Tohoku university school, Tomography, Torticollis, Toxin, Tremor, Trinucleotide, Trinucleotide expansion, Unilateral stimulation, Ventralis oralis, Video, Video segment, Videotape, Wiley interscience.
Abstract
We report on a young woman from the United Kingdom with L‐dopa–responsive parkinsonism with a trinucleotide repeat expansion in her spinocerebellar ataxia 2 (SCA2) gene. The case further extends the phenotype of SCA2 and emphasizes the importance of SCA screening in young‐onset parkinsonism, irrespective of ethnic origin. © 2004 Movement Disorder Society
Url:
DOI: 10.1002/mds.10715
Links to Exploration step
ISTEX:60163DD9E3887A992F60E772EFEFFCCE890DA0E7Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report</title>
<author><name sortKey="Wilkins, Alastair" sort="Wilkins, Alastair" uniqKey="Wilkins A" first="Alastair" last="Wilkins">Alastair Wilkins</name>
<affiliation><mods:affiliation>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Brown, Jerry M" sort="Brown, Jerry M" uniqKey="Brown J" first="Jerry M." last="Brown">Jerry M. Brown</name>
<affiliation><mods:affiliation>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Barker, Roger A" sort="Barker, Roger A" uniqKey="Barker R" first="Roger A." last="Barker">Roger A. Barker</name>
<affiliation><mods:affiliation>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>E-mail: rab46@cus.cam.ac.uk</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Correspondence address: Department of Neurology, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:60163DD9E3887A992F60E772EFEFFCCE890DA0E7</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.10715</idno>
<idno type="url">https://api.istex.fr/document/60163DD9E3887A992F60E772EFEFFCCE890DA0E7/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002F17</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002F17</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report<ref type="note" target="#fn1"></ref>
</title>
<author><name sortKey="Wilkins, Alastair" sort="Wilkins, Alastair" uniqKey="Wilkins A" first="Alastair" last="Wilkins">Alastair Wilkins</name>
<affiliation><mods:affiliation>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Brown, Jerry M" sort="Brown, Jerry M" uniqKey="Brown J" first="Jerry M." last="Brown">Jerry M. Brown</name>
<affiliation><mods:affiliation>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Barker, Roger A" sort="Barker, Roger A" uniqKey="Barker R" first="Roger A." last="Barker">Roger A. Barker</name>
<affiliation><mods:affiliation>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>E-mail: rab46@cus.cam.ac.uk</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Correspondence address: Department of Neurology, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Movement Disorders</title>
<title level="j" type="alt">MOVEMENT DISORDERS</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><biblScope unit="vol">19</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="593">593</biblScope>
<biblScope unit="page" to="595">595</biblScope>
<biblScope unit="page-count">2</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-05">2004-05</date>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abnormal</term>
<term>Abnormal activity</term>
<term>Abnormal movements</term>
<term>Acta</term>
<term>Acta neuropathol</term>
<term>Allele</term>
<term>Anterocollis</term>
<term>Ataxia</term>
<term>Atrophy</term>
<term>Autosomal</term>
<term>Axial right</term>
<term>Basal</term>
<term>Basal ganglia</term>
<term>Biceps brachii</term>
<term>Bilateral</term>
<term>Bilateral stimulation</term>
<term>Bilaterally</term>
<term>Botox</term>
<term>Botulinum</term>
<term>Botulinum toxin</term>
<term>Botulinum toxin type</term>
<term>Bradykinesia</term>
<term>Case report</term>
<term>Caudate</term>
<term>Caudate nucleus</term>
<term>Cerebellar</term>
<term>Cerebellar ataxia</term>
<term>Cervical</term>
<term>Cervical dystonia</term>
<term>Chorea</term>
<term>Choreic movements</term>
<term>Choreiform</term>
<term>Choreiform movements</term>
<term>Clinical features</term>
<term>Clinical outcome</term>
<term>Cogwheel rigidity</term>
<term>Colli</term>
<term>Contralateral</term>
<term>Cyclohydrolase</term>
<term>Deep brain stimulation</term>
<term>Degenerative ataxias</term>
<term>Dentatorubral</term>
<term>Dentatorubral pallidoluysian atrophy</term>
<term>Disord</term>
<term>Disorder</term>
<term>Dopamine</term>
<term>Drpla</term>
<term>Dyskinesia</term>
<term>Dystonia</term>
<term>Dystonic</term>
<term>Dystonic posture</term>
<term>Extrapyramidal</term>
<term>Familial cases</term>
<term>Family history</term>
<term>Ganglion</term>
<term>Genet</term>
<term>Genetic studies</term>
<term>Globus</term>
<term>Globus pallidum</term>
<term>Globus pallidus</term>
<term>Globus pallidus internus</term>
<term>Hereditary</term>
<term>Imaging</term>
<term>Inclusion</term>
<term>Interscience</term>
<term>Intramuscular</term>
<term>Intranuclear</term>
<term>Intranuclear inclusions</term>
<term>Involuntary movements</term>
<term>Jerk</term>
<term>Lancet</term>
<term>Longus</term>
<term>Longus colli</term>
<term>Magnetic resonance imaging</term>
<term>Moderate improvement</term>
<term>Movement disorder society</term>
<term>Movement disorders</term>
<term>Mutant</term>
<term>Mutation</term>
<term>Myoclonus</term>
<term>Nding</term>
<term>Ndings</term>
<term>Neurol</term>
<term>Neurol neurosurg psychiatry</term>
<term>Neurological</term>
<term>Neurology</term>
<term>Neuron</term>
<term>Neuronal</term>
<term>Neuropathological</term>
<term>Neuropathological features</term>
<term>Neurosurg</term>
<term>Normal values</term>
<term>October</term>
<term>Online</term>
<term>Oromandibular dystonia</term>
<term>Pallidal</term>
<term>Pallidal stimulation</term>
<term>Pallidoluysian</term>
<term>Pallidum</term>
<term>Pallidus</term>
<term>Parkinsonism</term>
<term>Perfusion</term>
<term>Phenotype</term>
<term>Propriospinal</term>
<term>Propriospinal myoclonus</term>
<term>Puncture site</term>
<term>Putamen</term>
<term>Radcliffe oxford</term>
<term>Rectus</term>
<term>Rectus abdominis</term>
<term>Rectus femoris</term>
<term>Right longus colli muscle</term>
<term>Rinsho shinkeigaku</term>
<term>Sca1</term>
<term>Sca2</term>
<term>Sca2 allele</term>
<term>Senile chorea</term>
<term>Several years</term>
<term>Severe anterocollis</term>
<term>Side effects</term>
<term>Single photon emission tomography</term>
<term>Spasmodic torticollis</term>
<term>Spet</term>
<term>Spinal</term>
<term>Spinocerebellar</term>
<term>Spinocerebellar ataxia</term>
<term>Spinocerebellar ataxia type</term>
<term>Sporadic case</term>
<term>Sporadic cases</term>
<term>Sternocleidomastoid</term>
<term>Sternocleidomastoid muscle</term>
<term>Sternocleidomastoid muscles</term>
<term>Sternocleidomastoideus</term>
<term>Stimulation</term>
<term>Stimulator</term>
<term>Subthalamic</term>
<term>Subthalamic nucleus</term>
<term>Symptom</term>
<term>Tardive</term>
<term>Tardive dyskinesia</term>
<term>Thalamic</term>
<term>Thalamic stimulation</term>
<term>Thalamus</term>
<term>Tohoku university school</term>
<term>Tomography</term>
<term>Torticollis</term>
<term>Toxin</term>
<term>Tremor</term>
<term>Trinucleotide</term>
<term>Trinucleotide expansion</term>
<term>Unilateral stimulation</term>
<term>Ventralis oralis</term>
<term>Video</term>
<term>Video segment</term>
<term>Videotape</term>
<term>Wiley interscience</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Abnormal</term>
<term>Abnormal activity</term>
<term>Abnormal movements</term>
<term>Acta</term>
<term>Acta neuropathol</term>
<term>Allele</term>
<term>Anterocollis</term>
<term>Ataxia</term>
<term>Atrophy</term>
<term>Autosomal</term>
<term>Axial right</term>
<term>Basal</term>
<term>Basal ganglia</term>
<term>Biceps brachii</term>
<term>Bilateral</term>
<term>Bilateral stimulation</term>
<term>Bilaterally</term>
<term>Botox</term>
<term>Botulinum</term>
<term>Botulinum toxin</term>
<term>Botulinum toxin type</term>
<term>Bradykinesia</term>
<term>Case report</term>
<term>Caudate</term>
<term>Caudate nucleus</term>
<term>Cerebellar</term>
<term>Cerebellar ataxia</term>
<term>Cervical</term>
<term>Cervical dystonia</term>
<term>Chorea</term>
<term>Choreic movements</term>
<term>Choreiform</term>
<term>Choreiform movements</term>
<term>Clinical features</term>
<term>Clinical outcome</term>
<term>Cogwheel rigidity</term>
<term>Colli</term>
<term>Contralateral</term>
<term>Cyclohydrolase</term>
<term>Deep brain stimulation</term>
<term>Degenerative ataxias</term>
<term>Dentatorubral</term>
<term>Dentatorubral pallidoluysian atrophy</term>
<term>Disord</term>
<term>Disorder</term>
<term>Dopamine</term>
<term>Drpla</term>
<term>Dyskinesia</term>
<term>Dystonia</term>
<term>Dystonic</term>
<term>Dystonic posture</term>
<term>Extrapyramidal</term>
<term>Familial cases</term>
<term>Family history</term>
<term>Ganglion</term>
<term>Genet</term>
<term>Genetic studies</term>
<term>Globus</term>
<term>Globus pallidum</term>
<term>Globus pallidus</term>
<term>Globus pallidus internus</term>
<term>Hereditary</term>
<term>Imaging</term>
<term>Inclusion</term>
<term>Interscience</term>
<term>Intramuscular</term>
<term>Intranuclear</term>
<term>Intranuclear inclusions</term>
<term>Involuntary movements</term>
<term>Jerk</term>
<term>Lancet</term>
<term>Longus</term>
<term>Longus colli</term>
<term>Magnetic resonance imaging</term>
<term>Moderate improvement</term>
<term>Movement disorder society</term>
<term>Movement disorders</term>
<term>Mutant</term>
<term>Mutation</term>
<term>Myoclonus</term>
<term>Nding</term>
<term>Ndings</term>
<term>Neurol</term>
<term>Neurol neurosurg psychiatry</term>
<term>Neurological</term>
<term>Neurology</term>
<term>Neuron</term>
<term>Neuronal</term>
<term>Neuropathological</term>
<term>Neuropathological features</term>
<term>Neurosurg</term>
<term>Normal values</term>
<term>October</term>
<term>Online</term>
<term>Oromandibular dystonia</term>
<term>Pallidal</term>
<term>Pallidal stimulation</term>
<term>Pallidoluysian</term>
<term>Pallidum</term>
<term>Pallidus</term>
<term>Parkinsonism</term>
<term>Perfusion</term>
<term>Phenotype</term>
<term>Propriospinal</term>
<term>Propriospinal myoclonus</term>
<term>Puncture site</term>
<term>Putamen</term>
<term>Radcliffe oxford</term>
<term>Rectus</term>
<term>Rectus abdominis</term>
<term>Rectus femoris</term>
<term>Right longus colli muscle</term>
<term>Rinsho shinkeigaku</term>
<term>Sca1</term>
<term>Sca2</term>
<term>Sca2 allele</term>
<term>Senile chorea</term>
<term>Several years</term>
<term>Severe anterocollis</term>
<term>Side effects</term>
<term>Single photon emission tomography</term>
<term>Spasmodic torticollis</term>
<term>Spet</term>
<term>Spinal</term>
<term>Spinocerebellar</term>
<term>Spinocerebellar ataxia</term>
<term>Spinocerebellar ataxia type</term>
<term>Sporadic case</term>
<term>Sporadic cases</term>
<term>Sternocleidomastoid</term>
<term>Sternocleidomastoid muscle</term>
<term>Sternocleidomastoid muscles</term>
<term>Sternocleidomastoideus</term>
<term>Stimulation</term>
<term>Stimulator</term>
<term>Subthalamic</term>
<term>Subthalamic nucleus</term>
<term>Symptom</term>
<term>Tardive</term>
<term>Tardive dyskinesia</term>
<term>Thalamic</term>
<term>Thalamic stimulation</term>
<term>Thalamus</term>
<term>Tohoku university school</term>
<term>Tomography</term>
<term>Torticollis</term>
<term>Toxin</term>
<term>Tremor</term>
<term>Trinucleotide</term>
<term>Trinucleotide expansion</term>
<term>Unilateral stimulation</term>
<term>Ventralis oralis</term>
<term>Video</term>
<term>Video segment</term>
<term>Videotape</term>
<term>Wiley interscience</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report on a young woman from the United Kingdom with L‐dopa–responsive parkinsonism with a trinucleotide repeat expansion in her spinocerebellar ataxia 2 (SCA2) gene. The case further extends the phenotype of SCA2 and emphasizes the importance of SCA screening in young‐onset parkinsonism, irrespective of ethnic origin. © 2004 Movement Disorder Society</div>
</front>
</TEI>
<istex><corpusName>wiley</corpusName>
<keywords><teeft><json:string>dystonia</json:string>
<json:string>ataxia</json:string>
<json:string>neurol</json:string>
<json:string>dyskinesia</json:string>
<json:string>chorea</json:string>
<json:string>movement disorders</json:string>
<json:string>neurology</json:string>
<json:string>mutation</json:string>
<json:string>parkinsonism</json:string>
<json:string>sca2</json:string>
<json:string>basal</json:string>
<json:string>spet</json:string>
<json:string>spinocerebellar</json:string>
<json:string>myoclonus</json:string>
<json:string>anterocollis</json:string>
<json:string>drpla</json:string>
<json:string>ganglion</json:string>
<json:string>cerebellar</json:string>
<json:string>globus</json:string>
<json:string>longus</json:string>
<json:string>pallidal</json:string>
<json:string>propriospinal</json:string>
<json:string>phenotype</json:string>
<json:string>tardive</json:string>
<json:string>trinucleotide</json:string>
<json:string>sca1</json:string>
<json:string>cervical</json:string>
<json:string>thalamic</json:string>
<json:string>colli</json:string>
<json:string>botox</json:string>
<json:string>botulinum toxin</json:string>
<json:string>intranuclear</json:string>
<json:string>disord</json:string>
<json:string>contralateral</json:string>
<json:string>deep brain stimulation</json:string>
<json:string>dystonic</json:string>
<json:string>pallidus</json:string>
<json:string>ndings</json:string>
<json:string>spinal</json:string>
<json:string>nding</json:string>
<json:string>neurosurg</json:string>
<json:string>tomography</json:string>
<json:string>torticollis</json:string>
<json:string>spinocerebellar ataxia type</json:string>
<json:string>allele</json:string>
<json:string>october</json:string>
<json:string>extrapyramidal</json:string>
<json:string>putamen</json:string>
<json:string>neuropathological</json:string>
<json:string>propriospinal myoclonus</json:string>
<json:string>dopamine</json:string>
<json:string>cyclohydrolase</json:string>
<json:string>perfusion</json:string>
<json:string>subthalamic</json:string>
<json:string>sternocleidomastoid</json:string>
<json:string>rectus</json:string>
<json:string>neurol neurosurg psychiatry</json:string>
<json:string>pallidum</json:string>
<json:string>autosomal</json:string>
<json:string>cervical dystonia</json:string>
<json:string>sternocleidomastoideus</json:string>
<json:string>toxin</json:string>
<json:string>botulinum</json:string>
<json:string>bradykinesia</json:string>
<json:string>videotape</json:string>
<json:string>tardive dyskinesia</json:string>
<json:string>side effects</json:string>
<json:string>stimulator</json:string>
<json:string>wiley interscience</json:string>
<json:string>online</json:string>
<json:string>choreiform</json:string>
<json:string>movement disorder society</json:string>
<json:string>mutant</json:string>
<json:string>pallidoluysian</json:string>
<json:string>lancet</json:string>
<json:string>acta</json:string>
<json:string>bilaterally</json:string>
<json:string>subthalamic nucleus</json:string>
<json:string>basal ganglia</json:string>
<json:string>intramuscular</json:string>
<json:string>dentatorubral</json:string>
<json:string>caudate</json:string>
<json:string>genet</json:string>
<json:string>thalamus</json:string>
<json:string>neurological</json:string>
<json:string>spinocerebellar ataxia</json:string>
<json:string>magnetic resonance imaging</json:string>
<json:string>sternocleidomastoid muscles</json:string>
<json:string>intranuclear inclusions</json:string>
<json:string>rinsho shinkeigaku</json:string>
<json:string>family history</json:string>
<json:string>spasmodic torticollis</json:string>
<json:string>ventralis oralis</json:string>
<json:string>globus pallidus internus</json:string>
<json:string>thalamic stimulation</json:string>
<json:string>senile chorea</json:string>
<json:string>longus colli</json:string>
<json:string>case report</json:string>
<json:string>severe anterocollis</json:string>
<json:string>caudate nucleus</json:string>
<json:string>video</json:string>
<json:string>jerk</json:string>
<json:string>pallidal stimulation</json:string>
<json:string>acta neuropathol</json:string>
<json:string>video segment</json:string>
<json:string>rectus abdominis</json:string>
<json:string>sporadic cases</json:string>
<json:string>globus pallidum</json:string>
<json:string>sporadic case</json:string>
<json:string>dystonic posture</json:string>
<json:string>involuntary movements</json:string>
<json:string>oromandibular dystonia</json:string>
<json:string>dentatorubral pallidoluysian atrophy</json:string>
<json:string>disorder</json:string>
<json:string>interscience</json:string>
<json:string>neuronal</json:string>
<json:string>hereditary</json:string>
<json:string>bilateral</json:string>
<json:string>imaging</json:string>
<json:string>neuron</json:string>
<json:string>sternocleidomastoid muscle</json:string>
<json:string>genetic studies</json:string>
<json:string>puncture site</json:string>
<json:string>botulinum toxin type</json:string>
<json:string>trinucleotide expansion</json:string>
<json:string>moderate improvement</json:string>
<json:string>neuropathological features</json:string>
<json:string>familial cases</json:string>
<json:string>clinical outcome</json:string>
<json:string>clinical features</json:string>
<json:string>tohoku university school</json:string>
<json:string>degenerative ataxias</json:string>
<json:string>bilateral stimulation</json:string>
<json:string>choreic movements</json:string>
<json:string>cerebellar ataxia</json:string>
<json:string>several years</json:string>
<json:string>normal values</json:string>
<json:string>sca2 allele</json:string>
<json:string>cogwheel rigidity</json:string>
<json:string>globus pallidus</json:string>
<json:string>right longus colli muscle</json:string>
<json:string>biceps brachii</json:string>
<json:string>abnormal activity</json:string>
<json:string>axial right</json:string>
<json:string>rectus femoris</json:string>
<json:string>abnormal movements</json:string>
<json:string>radcliffe oxford</json:string>
<json:string>choreiform movements</json:string>
<json:string>single photon emission tomography</json:string>
<json:string>unilateral stimulation</json:string>
<json:string>symptom</json:string>
<json:string>inclusion</json:string>
<json:string>atrophy</json:string>
<json:string>stimulation</json:string>
<json:string>tremor</json:string>
<json:string>abnormal</json:string>
</teeft>
</keywords>
<author><json:item><name>Alastair Wilkins PhD, MRCP</name>
<affiliations><json:string>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom</json:string>
</affiliations>
</json:item>
<json:item><name>Jerry M. Brown MD, MRCP</name>
<affiliations><json:string>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom</json:string>
</affiliations>
</json:item>
<json:item><name>Roger A. Barker PhD, MRCP</name>
<affiliations><json:string>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom</json:string>
<json:string>E-mail: rab46@cus.cam.ac.uk</json:string>
<json:string>Correspondence address: Department of Neurology, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK</json:string>
</affiliations>
</json:item>
</author>
<subject><json:item><lang><json:string>eng</json:string>
</lang>
<value>SCA2</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>parkinsonism</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>levodopa</value>
</json:item>
</subject>
<articleId><json:string>MDS10715</json:string>
</articleId>
<arkIstex>ark:/67375/WNG-HCNJDV2R-1</arkIstex>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>shortCommunication</json:string>
</originalGenre>
<abstract>We report on a young woman from the United Kingdom with L‐dopa–responsive parkinsonism with a trinucleotide repeat expansion in her spinocerebellar ataxia 2 (SCA2) gene. The case further extends the phenotype of SCA2 and emphasizes the importance of SCA screening in young‐onset parkinsonism, irrespective of ethnic origin. © 2004 Movement Disorder Society</abstract>
<qualityIndicators><refBibsNative>true</refBibsNative>
<abstractWordCount>52</abstractWordCount>
<abstractCharCount>356</abstractCharCount>
<keywordCount>3</keywordCount>
<score>7.624</score>
<pdfWordCount>15014</pdfWordCount>
<pdfCharCount>98428</pdfCharCount>
<pdfVersion>1.3</pdfVersion>
<pdfPageCount>23</pdfPageCount>
<pdfPageSize>612 x 810 pts</pdfPageSize>
</qualityIndicators>
<title>SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report</title>
<pmid><json:string>15133829</json:string>
</pmid>
<genre><json:string>brief-communication</json:string>
</genre>
<host><title>Movement Disorders</title>
<language><json:string>unknown</json:string>
</language>
<doi><json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
<issn><json:string>0885-3185</json:string>
</issn>
<eissn><json:string>1531-8257</json:string>
</eissn>
<publisherId><json:string>MDS</json:string>
</publisherId>
<volume>19</volume>
<issue>5</issue>
<pages><first>593</first>
<last>595</last>
<total>2</total>
</pages>
<genre><json:string>journal</json:string>
</genre>
<subject><json:item><value>Clinical/Scientific Note with Video</value>
</json:item>
</subject>
</host>
<namedEntities><unitex><date><json:string>1994</json:string>
<json:string>1984</json:string>
<json:string>2004</json:string>
</date>
<geogName></geogName>
<orgName><json:string>University of Toronto</json:string>
<json:string>Department of Pathology</json:string>
<json:string>Department of Laboratory Medicine</json:string>
<json:string>Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada Abstract</json:string>
<json:string>Toronto Western Hospital, Toronto, ON, Canada</json:string>
</orgName>
<orgName_funder></orgName_funder>
<orgName_provider></orgName_provider>
<persName><json:string>Iizuka</json:string>
<json:string>Anthony E. Lang</json:string>
<json:string>Catherine Bergeron</json:string>
</persName>
<placeName><json:string>Canada</json:string>
</placeName>
<ref_url></ref_url>
<ref_bibl></ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark><json:string>ark:/67375/WNG-HCNJDV2R-1</json:string>
</ark>
<categories><wos><json:string>1 - science</json:string>
<json:string>2 - clinical neurology</json:string>
</wos>
<scienceMetrix><json:string>1 - health sciences</json:string>
<json:string>2 - clinical medicine</json:string>
<json:string>3 - neurology & neurosurgery</json:string>
</scienceMetrix>
<scopus><json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Clinical Neurology</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Neuroscience</json:string>
<json:string>3 - Neurology</json:string>
</scopus>
<inist><json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences medicales</json:string>
<json:string>4 - neurologie</json:string>
</inist>
</categories>
<publicationDate>2004</publicationDate>
<copyrightDate>2004</copyrightDate>
<doi><json:string>10.1002/mds.10715</json:string>
</doi>
<id>60163DD9E3887A992F60E772EFEFFCCE890DA0E7</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/60163DD9E3887A992F60E772EFEFFCCE890DA0E7/fulltext/pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/60163DD9E3887A992F60E772EFEFFCCE890DA0E7/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/60163DD9E3887A992F60E772EFEFFCCE890DA0E7/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report<ref type="note" target="#fn1"></ref>
</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability><licence>Copyright © 2004 Movement Disorder Society</licence>
</availability>
<date type="published" when="2004-05"></date>
</publicationStmt>
<notesStmt><note type="content-type" subtype="brief-communication" source="shortCommunication" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-S9SX2MFS-0">brief-communication</note>
<note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc><biblStruct type="brief-communication"><analytic><title level="a" type="main" xml:lang="en">SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report<ref type="note" target="#fn1"></ref>
</title>
<title level="a" type="short" xml:lang="en">Clinical/Scientific Notes</title>
<author xml:id="author-0000"><persName><forename type="first">Alastair</forename>
<surname>Wilkins</surname>
<roleName type="degree">PhD, MRCP</roleName>
</persName>
<affiliation>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom<address><country key="GB"></country>
</address>
</affiliation>
</author>
<author xml:id="author-0001"><persName><forename type="first">Jerry M.</forename>
<surname>Brown</surname>
<roleName type="degree">MD, MRCP</roleName>
</persName>
<affiliation>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom<address><country key="GB"></country>
</address>
</affiliation>
</author>
<author xml:id="author-0002" role="corresp"><persName><forename type="first">Roger A.</forename>
<surname>Barker</surname>
<roleName type="degree">PhD, MRCP</roleName>
</persName>
<email>rab46@cus.cam.ac.uk</email>
<affiliation>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom<address><country key="GB"></country>
</address>
</affiliation>
<affiliation>Department of Neurology, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK</affiliation>
</author>
<idno type="istex">60163DD9E3887A992F60E772EFEFFCCE890DA0E7</idno>
<idno type="ark">ark:/67375/WNG-HCNJDV2R-1</idno>
<idno type="DOI">10.1002/mds.10715</idno>
<idno type="unit">MDS10715</idno>
<idno type="toTypesetVersion">file:MDS.MDS10715.pdf</idno>
</analytic>
<monogr><title level="j" type="main">Movement Disorders</title>
<title level="j" type="alt">MOVEMENT DISORDERS</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="book-DOI">10.1002/(ISSN)1531-8257</idno>
<idno type="book-part-DOI">10.1002/mds.v19:5</idno>
<idno type="product">MDS</idno>
<imprint><biblScope unit="vol">19</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="593">593</biblScope>
<biblScope unit="page" to="595">595</biblScope>
<biblScope unit="page-count">2</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-05"></date>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><abstract xml:lang="en" style="main"><head>Abstract</head>
<p>We report on a young woman from the United Kingdom with <hi rend="smallCaps">L</hi>
‐dopa–responsive parkinsonism with a trinucleotide repeat expansion in her spinocerebellar ataxia 2 (SCA2) gene. The case further extends the phenotype of SCA2 and emphasizes the importance of SCA screening in young‐onset parkinsonism, irrespective of ethnic origin. © 2004 Movement Disorder Society</p>
</abstract>
<textClass><keywords xml:lang="en"><term xml:id="kwd1">SCA2</term>
<term xml:id="kwd2">parkinsonism</term>
<term xml:id="kwd3">levodopa</term>
</keywords>
<keywords rend="articleCategory"><term>Clinical/Scientific Note with Video</term>
</keywords>
<keywords rend="tocHeading1"><term>Clinical/Scientific Notes</term>
</keywords>
</textClass>
<langUsage><language ident="en"></language>
</langUsage>
</profileDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/60163DD9E3887A992F60E772EFEFFCCE890DA0E7/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup><id type="product" value="MDS"></id>
</idGroup>
<titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="subtitle">Official Journal of the Movement Disorder Society</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="50"><doi origin="wiley" registered="yes">10.1002/mds.v19:5</doi>
<numberingGroup><numbering type="journalVolume" number="19">19</numbering>
<numbering type="journalIssue">5</numbering>
</numberingGroup>
<coverDate startDate="2004-05">May 2004</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="shortCommunication" position="190" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.10715</doi>
<idGroup><id type="unit" value="MDS10715"></id>
</idGroup>
<countGroup><count type="pageTotal" number="2"></count>
</countGroup>
<titleGroup><title type="articleCategory">Clinical/Scientific Note with Video</title>
<title type="tocHeading1">Clinical/Scientific Notes</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 2004 Movement Disorder Society</copyright>
<eventGroup><event type="manuscriptReceived" date="2003-07-06"></event>
<event type="manuscriptRevised" date="2003-10-10"></event>
<event type="manuscriptAccepted" date="2003-10-21"></event>
<event type="publishedOnlineEarlyUnpaginated" date="2004-01-05"></event>
<event type="firstOnline" date="2004-01-05"></event>
<event type="publishedOnlineFinalForm" date="2004-05-03"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:FullText result:FullText" date="2010-03-09"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event>
</eventGroup>
<numberingGroup><numbering type="pageFirst">593</numbering>
<numbering type="pageLast">595</numbering>
</numberingGroup>
<correspondenceTo>Department of Neurology, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK</correspondenceTo>
<linkGroup><link type="toTypesetVersion" href="file:MDS.MDS10715.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta><countGroup><count type="figureTotal" number="0"></count>
<count type="tableTotal" number="0"></count>
<count type="referenceTotal" number="8"></count>
<count type="wordTotal" number="1192"></count>
</countGroup>
<titleGroup><title type="main" xml:lang="en">SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report<link href="#fn1"></link>
</title>
<title type="short" xml:lang="en">Clinical/Scientific Notes</title>
</titleGroup>
<creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Alastair</givenNames>
<familyName>Wilkins</familyName>
<degrees>PhD, MRCP</degrees>
</personName>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Jerry M.</givenNames>
<familyName>Brown</familyName>
<degrees>MD, MRCP</degrees>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Roger A.</givenNames>
<familyName>Barker</familyName>
<degrees>PhD, MRCP</degrees>
</personName>
<contactDetails><email>rab46@cus.cam.ac.uk</email>
</contactDetails>
</creator>
</creators>
<affiliationGroup><affiliation xml:id="af1" countryCode="GB" type="organization"><unparsedAffiliation>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">SCA2</keyword>
<keyword xml:id="kwd2">parkinsonism</keyword>
<keyword xml:id="kwd3">levodopa</keyword>
</keywordGroup>
<supportingInformation><p>
This article contains supplementary video clips, available online at
<url href="http://www.interscience.wiley.com/jpages/0885-3185/suppmat">
http://www.interscience.wiley.com/jpages/0885‐3185/suppmat
</url>
</p>
<supportingInfoItem><mediaResource alt="supporting information" href="urn-x:wiley:08853185:media:mds10715:suppmat_593"></mediaResource>
<caption>Supporting Information file suppmat_593.mpg</caption>
</supportingInfoItem>
</supportingInformation>
<abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title>
<p>We report on a young woman from the United Kingdom with <sc>L</sc>
‐dopa–responsive parkinsonism with a trinucleotide repeat expansion in her spinocerebellar ataxia 2 (SCA2) gene. The case further extends the phenotype of SCA2 and emphasizes the importance of SCA screening in young‐onset parkinsonism, irrespective of ethnic origin. © 2004 Movement Disorder Society</p>
</abstract>
</abstractGroup>
</contentMeta>
<noteGroup><note xml:id="fn1"><p>A videotape accompanies this article.</p>
</note>
</noteGroup>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo lang="en"><title>SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en"><title>Clinical/Scientific Notes</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en"><title>SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report</title>
</titleInfo>
<name type="personal"><namePart type="given">Alastair</namePart>
<namePart type="family">Wilkins</namePart>
<namePart type="termsOfAddress">PhD, MRCP</namePart>
<affiliation>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Jerry M.</namePart>
<namePart type="family">Brown</namePart>
<namePart type="termsOfAddress">MD, MRCP</namePart>
<affiliation>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Roger A.</namePart>
<namePart type="family">Barker</namePart>
<namePart type="termsOfAddress">PhD, MRCP</namePart>
<affiliation>Department of Neurology, Addenbrooke's Hospital, Cambridge, United Kingdom</affiliation>
<affiliation>E-mail: rab46@cus.cam.ac.uk</affiliation>
<affiliation>Correspondence address: Department of Neurology, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="brief-communication" displayLabel="shortCommunication" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-S9SX2MFS-0">brief-communication</genre>
<originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place><placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2004-05</dateIssued>
<dateCaptured encoding="w3cdtf">2003-07-06</dateCaptured>
<dateValid encoding="w3cdtf">2003-10-21</dateValid>
<copyrightDate encoding="w3cdtf">2004</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription><extent unit="figures">0</extent>
<extent unit="tables">0</extent>
<extent unit="references">8</extent>
<extent unit="words">1192</extent>
</physicalDescription>
<abstract lang="en">We report on a young woman from the United Kingdom with L‐dopa–responsive parkinsonism with a trinucleotide repeat expansion in her spinocerebellar ataxia 2 (SCA2) gene. The case further extends the phenotype of SCA2 and emphasizes the importance of SCA screening in young‐onset parkinsonism, irrespective of ethnic origin. © 2004 Movement Disorder Society</abstract>
<note type="content">*A videotape accompanies this article.</note>
<subject lang="en"><genre>keywords</genre>
<topic>SCA2</topic>
<topic>parkinsonism</topic>
<topic>levodopa</topic>
</subject>
<relatedItem type="host"><titleInfo><title>Movement Disorders</title>
<subTitle>Official Journal of the Movement Disorder Society</subTitle>
</titleInfo>
<titleInfo type="abbreviated"><title>Mov. Disord.</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<note type="content"> This article contains supplementary video clips, available online at http://www.interscience.wiley.com/jpages/0885‐3185/suppmatSupporting Info Item: Supporting Information file suppmat_593.mpg - </note>
<subject><genre>article-category</genre>
<topic>Clinical/Scientific Note with Video</topic>
</subject>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part><date>2004</date>
<detail type="volume"><caption>vol.</caption>
<number>19</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>5</number>
</detail>
<extent unit="pages"><start>593</start>
<end>595</end>
<total>2</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">60163DD9E3887A992F60E772EFEFFCCE890DA0E7</identifier>
<identifier type="ark">ark:/67375/WNG-HCNJDV2R-1</identifier>
<identifier type="DOI">10.1002/mds.10715</identifier>
<identifier type="ArticleID">MDS10715</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2004 Movement Disorder Society</accessCondition>
<recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource>
<recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
</recordInfo>
</mods>
<json:item><extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/document/60163DD9E3887A992F60E772EFEFFCCE890DA0E7/metadata/json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F17 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002F17 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= EdenteV2 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:60163DD9E3887A992F60E772EFEFFCCE890DA0E7 |texte= SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report }}
![]() | This area was generated with Dilib version V0.6.32. | ![]() |